Creatine monohydrate

N/A

Report date: 2024/11/02 20:00:07
NME

Base Information

Drug NameCreatine monohydrate
Drug Alias Name肌酸一水化物一水肌氨酸NEOtinePURE ENERGYPD-02 +[19] 
ClassificationSmall molecules > Amino acid supplement, Lipids and Vitamins
Mechanisms of ActionUndefined mechanism
TargetsNot applicable
Therapy Area/IndicationsSolid tumoursDepressive Disorder, MajorBipolar Disorder +[42] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesNew Zealand +[6] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesAvicena
China Registration ClassN/A

Develop Information

Active CompaniesUtah State UniversityMasonic Cancer Center, University Of MinnesotaFlorida State University +[4] 
Inactive CompaniesNational Institutes Of HealthNational Center For Complementary And Integrative HealthSuny Upstate Medical University +[14] 
Active IndicationsDepressive Disorder, MajorAnxietyDepression +[27] 
Inactive IndicationsSolid tumoursBipolar DisorderAnorexia +[15] 

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBank